The Role of MiR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: Evidence From LncRNA-miRNA-mRNA Network Analysis
Overview
Authors
Affiliations
Gastric cancer is a deadly human malignancy and the molecular mechanisms underlying gastric cancer pathophysiology are very complicated. Thus, further investigations are warranted to decipher the underlying molecular mechanisms. With the development of high-throughput screening and bioinformatics, gene expression profiles with large scale have been performed in gastric cancer. In the present study, we mined The Cancer Genome Atlas (TCGA) database and analyzed the gene expression profiles between gastric cancer tissues and normal gastric tissues. A series of differentially expressed lncRNAs, miRNAs and mRNAs between gastric cancer tissues and normal gastric tissues were identified. Based on the differentially expressed genes, we constructed miRNA-mRNA network, lncRNA-mRNA network and transcriptional factors-mRNA-miRNA-lncRNA network. Furthermore, the Kaplan survival analysis showed that high expression levels of EVX1, GBX2, GCM1, HOXC8, HOXC9, HOXC10, HOXC11, HOXC12 and HOXC13 were all significantly correlated with shorter overall survival of the patients with gastric cancer. On the other hand, low expression level of HOXA13 was associated with shorter overall survival of patients with gastric cancer. Among these hub genes, we performed the functional studies of HOXC8 in the gastric cancer cells. Knockdown of HOXC8 and overexpression of miR-4256 both significantly repressed the gastric cancer cell proliferation and migration, and miR-4256 repressed the expression of HOXC8 targeting its 3' untranslated region in gastric cancer cells. Collectively, our results revealed that a complex interaction networks of differentially expressed genes in gastric cancer, and further functional studies indicated that miR-4256/HOXC8 may be an important axis in regulating gastric cancer progression.
lncRNA WAC-AS1 promotes the progression of gastric cancer through miR-204-5p/HOXC8 axis.
Liu Y, Li K, Gao Y, Feng Y, Zhao X, Hou R Transl Oncol. 2024; 50():102139.
PMID: 39395273 PMC: 11736402. DOI: 10.1016/j.tranon.2024.102139.
Mechanism of salidroside in tumor suppression through the miRNA-mRNA signaling axis.
Wu X, Zhang Z, Wang X Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(5):810-817.
PMID: 39174895 PMC: 11341224. DOI: 10.11817/j.issn.1672-7347.2024.230480.
Liu Y, Yang L, Yu M, Huang F, Zeng J, Lu Y Open Med (Wars). 2023; 18(1):20230795.
PMID: 37724126 PMC: 10505303. DOI: 10.1515/med-2023-0795.
mediates osteopontin expression in gastric cancer cells.
Tsai C, Liao J, Lee Y, Yang Y J Cancer. 2023; 14(13):2552-2561.
PMID: 37670969 PMC: 10475364. DOI: 10.7150/jca.84460.
The SMAD2/miR-4256/HDAC5/p16 signaling axis contributes to gastric cancer progression.
Wang M, Zhao H, Chen W, Bie C, Yang J, Cai W Oncol Res. 2023; 31(4):515-541.
PMID: 37415735 PMC: 10319587. DOI: 10.32604/or.2023.029101.